Nantahala Capital Management, LLC

13D and 13G Filings

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing since 12/18/2024, newest first.

Issuer	Symbol	CUSIP	% of Class	Shares	Form	Filed
Evoke Pharma Inc 13D/A Amendment 4 EVOK · 30049G302	EVOK	30049G302	16.0%	268,431	13D/A Amendment 4	11/4/2025 Event 11/3/2025
Nantahala Capital Management, LLC			16.0%	268,431
Harkey Wilmot B.			16.0%	268,431
Mack Daniel			16.0%	268,431
Abeona Therapeutics Inc. 13G/A Amendment 4 ABEO · 00289Y206	ABEO	00289Y206	10.0%	5,184,662	13G/A Amendment 4	10/6/2025 Event 9/30/2025
Nantahala Capital Management, LLC			10.0%	5,184,662
Wilmot B. Harkey			10.0%	5,184,662
Daniel Mack			10.0%	5,184,662
Nektar Therapeutics 13G NKTR · 640268306	NKTR	640268306	5.7%	709,761	13G	8/14/2025 Event 6/30/2025
Nantahala Capital Management, LLC			5.7%	709,761
Wilmot B. Harkey			5.7%	709,761
Daniel Mack			5.7%	709,761
Immunic, Inc. 13G IMUX · 4525EP101	IMUX	4525EP101	10.0%	10,634,565	13G	8/14/2025 Event 6/30/2025
Nantahala Capital Management, LLC			10.0%	10,634,565
Wilmot B. Harkey			10.0%	10,634,565
Daniel Mack			10.0%	10,634,565
Herbalife Ltd. 13G/A Amendment 1 HLF · G4412G101	HLF	G4412G101	7.0%	7,122,298	13G/A Amendment 1	8/14/2025 Event 6/30/2025
Nantahala Capital Management, LLC			7.0%	7,122,298
Wilmot B. Harkey			7.0%	7,122,298
Daniel Mack			7.0%	7,122,298
Grace Therapeutics, Inc. 13G/A Amendment 1 GRCE · 00439U104	GRCE	00439U104	10.0%	1,404,032	13G/A Amendment 1	8/14/2025 Event 6/30/2025
Nantahala Capital Management, LLC			10.0%	1,404,032
Wilmot B. Harkey			10.0%	1,404,032
Daniel Mack			10.0%	1,404,032
Fossil Group, Inc. 13G/A Amendment 2 FOSL · 34988V106	FOSL	34988V106	9.5%	5,087,803	13G/A Amendment 2	8/14/2025 Event 6/30/2025
Nantahala Capital Management, LLC			9.5%	5,087,803
Wilmot B. Harkey			9.5%	5,087,803
Daniel Mack			9.5%	5,087,803
Eagle Pharmaceuticals, Inc. 13G/A Amendment 1 EGRX · 269796108	EGRX	269796108	38.1%	4,945,209	13G/A Amendment 1	8/14/2025 Event 6/30/2025
Nantahala Capital Management, LLC			38.1%	4,945,209
Wilmot B. Harkey			38.1%	4,945,209
Daniel Mack			38.1%	4,945,209
DarioHealth Corp. 13G/A Amendment 8 DRIO · 23725P209	DRIO	23725P209	10.0%	4,690,019	13G/A Amendment 8	8/14/2025 Event 6/30/2025
Nantahala Capital Management, LLC			10.0%	4,690,019
Wilmot B. Harkey			10.0%	4,690,019
Daniel Mack			10.0%	4,690,019
COMPASS Pathways plc 13G CMPS · 20451W101	CMPS	20451W101	6.2%	5,934,315	13G	8/14/2025 Event 6/30/2025
Nantahala Capital Management, LLC			6.2%	5,934,315
Wilmot B. Harkey			6.2%	5,934,315
Daniel Mack			6.2%	5,934,315
Cellectar Biosciences, Inc. 13G/A Amendment 3 CLRB · 15117F880	CLRB	15117F880	0.1%	1,109	13G/A Amendment 3	8/14/2025 Event 6/30/2025
Nantahala Capital Management, LLC			0.1%	1,109
Wilmot B. Harkey			0.1%	1,109
Daniel Mack			0.1%	1,109
uniQure N.V. 13G/A Amendment 8 QURE · N90064101	QURE	N90064101	3.8%	2,051,852	13G/A Amendment 8	8/14/2025 Event 6/30/2025
Nantahala Capital Management, LLC			3.8%	2,051,852
Wilmot B. Harkey			3.8%	2,051,852
Daniel Mack			3.8%	2,051,852
Unicycive Therapeutics, Inc. 13G/A Amendment 7 UNCY · 90466Y103	UNCY	90466Y103	10.0%	1,234,596	13G/A Amendment 7	8/14/2025 Event 6/30/2025
Nantahala Capital Management, LLC			10.0%	1,234,596
Wilmot B. Harkey			10.0%	1,234,596
Daniel Mack			10.0%	1,234,596
Trisalus Life Sciences, Inc. 13G TLSI · 89680M101	TLSI	89680M101	5.3%	2,000,000	13G	8/14/2025 Event 6/30/2025
Nantahala Capital Management, LLC			5.3%	2,000,000
Wilmot B. Harkey			5.3%	2,000,000
Daniel Mack			5.3%	2,000,000
Titan Machinery Inc. 13G/A Amendment 1 TITN · 88830R101	TITN	88830R101	4.9%	1,135,552	13G/A Amendment 1	8/14/2025 Event 6/30/2025
Nantahala Capital Management, LLC			4.9%	1,135,552
Wilmot B. Harkey			4.9%	1,135,552
Daniel Mack			4.9%	1,135,552
Surrozen, Inc./DE 13G/A Amendment 2 SRZN · 86889P208	SRZN	86889P208	5.2%	455,299	13G/A Amendment 2	8/14/2025 Event 6/30/2025
Nantahala Capital Management, LLC			5.2%	455,299
Wilmot B. Harkey			5.2%	455,299
Daniel Mack			5.2%	455,299
Soleno Therapeutics Inc 13G/A Amendment 9 SLNO · 834203309	SLNO	834203309	2.0%	1,001,350	13G/A Amendment 9	8/14/2025 Event 6/30/2025
Nantahala Capital Management, LLC			2.0%	1,001,350
Wilmot B. Harkey			2.0%	1,001,350
Daniel Mack			2.0%	1,001,350
RMR Group Inc. 13G/A Amendment 3 RMR · 74967R106	RMR	74967R106	7.2%	1,147,902	13G/A Amendment 3	8/14/2025 Event 6/30/2025
Nantahala Capital Management, LLC			7.2%	1,147,902
Wilmot B. Harkey			7.2%	1,147,902
Daniel Mack			7.2%	1,147,902
RAPT Therapeutics, Inc. 13G RAPT · 75382E208	RAPT	75382E208	5.8%	951,613	13G	8/14/2025 Event 6/30/2025
Nantahala Capital Management, LLC			5.8%	951,613
Wilmot B. Harkey			5.8%	951,613
Daniel Mack			5.8%	951,613
Quince Therapeutics, Inc. 13G QNCX · 22053A107	QNCX	22053A107	10.0%	4,765,862	13G	8/14/2025 Event 6/30/2025
Nantahala Capital Management, LLC			10.0%	4,765,862
Wilmot B. Harkey			10.0%	4,765,862
Daniel Mack			10.0%	4,765,862
Opus Genetics, Inc. 13G/A Amendment 1 IRD · 67577R102	IRD	67577R102	10.0%	6,250,299	13G/A Amendment 1	8/14/2025 Event 6/30/2025
Nantahala Capital Management, LLC			10.0%	6,250,299
Wilmot B. Harkey			10.0%	6,250,299
Daniel Mack			10.0%	6,250,299
Optinose, Inc. 13G/A Amendment 2 OPTN · 68404V209	OPTN	68404V209	0%	0	13G/A Amendment 2	8/14/2025 Event 6/30/2025
Nantahala Capital Management, LLC			0%	0
Wilmot B. Harkey			0%	0
Daniel Mack			0%	0
Bioventus Inc. 13G/A Amendment 3 BVS · 09075A108	BVS	09075A108	8.0%	5,280,842	13G/A Amendment 3	8/14/2025 Event 6/30/2025
Nantahala Capital Management, LLC			8.0%	5,280,842
Wilmot B. Harkey			8.0%	5,280,842
Daniel Mack			8.0%	5,280,842
1 800 Flowers Com Inc 13G FLWS · 68243Q106	FLWS	68243Q106	5.5%	2,000,000	13G	8/14/2025 Event 6/30/2025
Nantahala Capital Management, LLC			5.5%	2,000,000
Wilmot B. Harkey			5.5%	2,000,000
Daniel Mack			5.5%	2,000,000
Xtant Medical Holdings, Inc. 13D/A Amendment 1 XTNT · 98420P308	XTNT	98420P308	49.1%	68,394,000	13D/A Amendment 1	8/5/2025 Event 8/1/2025
Nantahala Capital Partners Limited Partnership			11.8%	16,380,396
Nantahala Capital Management, LLC			49.1%	68,394,000
Harkey Wilmot B.			49.1%	68,394,000
Mack Daniel			49.1%	68,394,000
Aytu Biopharma, Inc 13D/A Amendment 3 AYTU · 054754858	AYTU	054754858	14.4%	1,086,812	13D/A Amendment 3	6/9/2025 Event 6/6/2025
Nantahala Capital Management, LLC			14.4%	1,086,812
Harkey Wilmot B.			14.4%	1,086,812
Mack Daniel			14.4%	1,086,812
Fossil Group, Inc. 13G/A Amendment 1 FOSL · 34988V106	FOSL	34988V106	7.9%	4,189,177	13G/A Amendment 1	5/15/2025 Event 3/31/2025
Nantahala Capital Management, LLC			7.9%	4,189,177
Wilmot B. Harkey			7.9%	4,189,177
Daniel Mack			7.9%	4,189,177
Elutia Inc. 13G/A Amendment 2 ELUT · 05479K106	ELUT	05479K106	10.0%	3,689,067	13G/A Amendment 2	5/15/2025 Event 3/31/2025
Nantahala Capital Management, LLC			10.0%	3,689,067
Wilmot B. Harkey			10.0%	3,689,067
Daniel Mack			10.0%	3,689,067
Evolus, Inc. 13G EOLS · 30052C107	EOLS	30052C107	5.9%	3,751,343	13G	5/15/2025 Event 3/31/2025
Nantahala Capital Management, LLC			5.9%	3,751,343
Wilmot B. Harkey			5.9%	3,751,343
Daniel Mack			5.9%	3,751,343
Ehealth, Inc. 13G/A Amendment 1 EHTH · 28238P109	EHTH	28238P109	4.4%	1,311,441	13G/A Amendment 1	5/15/2025 Event 3/31/2025
Nantahala Capital Management, LLC			4.4%	1,311,441
Wilmot B. Harkey			4.4%	1,311,441
Daniel Mack			4.4%	1,311,441
Grace Therapeutics, Inc. 13G GRCE · 00439U104	GRCE	00439U104	10.0%	1,391,773	13G	5/15/2025 Event 3/31/2025
Nantahala Capital Management, LLC			10.0%	1,391,773
Wilmot B. Harkey			10.0%	1,391,773
Daniel Mack			10.0%	1,391,773
Edesa Biotech, Inc. 13G EDSA · 27966L306	EDSA	27966L306	10.0%	700,488	13G	5/15/2025 Event 3/31/2025
Nantahala Capital Management, LLC			10.0%	700,488
Wilmot B. Harkey			10.0%	700,488
Daniel Mack			10.0%	700,488
Gaia, Inc. 13G/A Amendment 2 GAIA · 36269P104	GAIA	36269P104	4.7%	914,618	13G/A Amendment 2	5/15/2025 Event 3/31/2025
Nantahala Capital Management, LLC			4.7%	914,618
Wilmot B. Harkey			4.7%	914,618
Daniel Mack			4.7%	914,618
Senti Biosciences, Inc. 13G/A Amendment 1 SNTI · 81726A209	SNTI	81726A209	8.1%	2,220,000	13G/A Amendment 1	5/15/2025 Event 3/31/2025
Nantahala Capital Management, LLC			8.1%	2,220,000
Wilmot B. Harkey			8.1%	2,220,000
Daniel Mack			8.1%	2,220,000
Altisource Portfolio Solutions S.A. 13G/A Amendment 1 ASPS · L0175J104	ASPS	L0175J104	2.8%	2,477,312	13G/A Amendment 1	5/15/2025 Event 3/31/2025
Nantahala Capital Management, LLC			2.8%	2,477,312
Wilmot B. Harkey			2.8%	2,477,312
Daniel Mack			2.8%	2,477,312
Abeona Therapeutics Inc. 13G/A Amendment 3 ABEO · 00289Y206	ABEO	00289Y206	10.0%	4,997,101	13G/A Amendment 3	5/15/2025 Event 3/31/2025
Nantahala Capital Management, LLC			10.0%	4,997,101
Wilmot B. Harkey			10.0%	4,997,101
Daniel Mack			10.0%	4,997,101
Verastem, Inc. 13G/A Amendment 2 VSTM · 92337C203	VSTM	92337C203	10.0%	5,459,278	13G/A Amendment 2	5/15/2025 Event 3/31/2025
Nantahala Capital Management, LLC			10.0%	5,459,278
Wilmot B. Harkey			10.0%	5,459,278
Daniel Mack			10.0%	5,459,278
BiomX Inc. 13G/A Amendment 1 PHGE · 09090D301	PHGE	09090D301	10.0%	2,494,197	13G/A Amendment 1	5/15/2025 Event 3/31/2025
Nantahala Capital Management, LLC			10.0%	2,494,197
Wilmot B. Harkey			10.0%	2,494,197
Daniel Mack			10.0%	2,494,197
Unicycive Therapeutics, Inc. 13G/A Amendment 6 UNCY · 90466Y103	UNCY	90466Y103	10.0%	12,243,386	13G/A Amendment 6	5/15/2025 Event 3/31/2025
Nantahala Capital Management, LLC			10.0%	12,243,386
Wilmot B. Harkey			10.0%	12,243,386
Daniel Mack			10.0%	12,243,386
Benitec Biopharma Inc. 13G/A Amendment 1 BNTC · 08205P209	BNTC	08205P209	4.4%	1,038,371	13G/A Amendment 1	5/15/2025 Event 3/31/2025
Nantahala Capital Management, LLC			4.4%	1,038,371
Wilmot B. Harkey			4.4%	1,038,371
Daniel Mack			4.4%	1,038,371
Third Harmonic Bio, Inc. 13G THRD · 88427A107	THRD	88427A107	6.5%	2,938,700	13G	5/15/2025 Event 3/31/2025
Nantahala Capital Management, LLC			6.5%	2,938,700
Wilmot B. Harkey			6.5%	2,938,700
Daniel Mack			6.5%	2,938,700
Senti Biosciences, Inc. 13G/A Amendment 1 SNTI · 81726A209	SNTI	81726A209	8.1%	2,220,000	13G/A Amendment 1	5/15/2025 Event 3/31/2025
Nantahala Capital Management, LLC			8.1%	2,220,000
Wilmot B. Harkey			8.1%	2,220,000
Daniel Mack			8.1%	2,220,000
Avalo Therapeutics, Inc. 13G AVTX · 05338F306	AVTX	05338F306	8.4%	900,000	13G	5/15/2025 Event 3/31/2025
Nantahala Capital Management, LLC			8.4%	900,000
Wilmot B. Harkey			8.4%	900,000
Daniel Mack			8.4%	900,000
Opus Genetics, Inc. 13G IRD · 67577R102	IRD	67577R102	10.0%	4,697,656	13G	5/15/2025 Event 3/31/2025
Nantahala Capital Management, LLC			10.0%	4,697,656
Wilmot B. Harkey			10.0%	4,697,656
Daniel Mack			10.0%	4,697,656
InspireMD, Inc. 13G/A Amendment 3 NSPR · 45779A846	NSPR	45779A846	10.0%	3,037,935	13G/A Amendment 3	5/15/2025 Event 3/31/2025
Nantahala Capital Management, LLC			10.0%	3,037,935
Wilmot B. Harkey			10.0%	3,037,935
Daniel Mack			10.0%	3,037,935
Herbalife Ltd. 13G HLF · G4412G101	HLF	G4412G101	5.8%	5,900,000	13G	5/15/2025 Event 3/31/2025
Nantahala Capital Management, LLC			5.8%	5,900,000
Wilmot B. Harkey			5.8%	5,900,000
Daniel Mack			5.8%	5,900,000
TELA Bio, Inc. 13G/A Amendment 2 TELA · 872381108	TELA	872381108	12.9%	5,111,588	13G/A Amendment 2	5/7/2025 Event 4/30/2025
Nantahala Capital Management, LLC			12.9%	5,111,588
Wilmot B. Harkey			12.9%	5,111,588
Daniel Mack			12.9%	5,111,588
Soleno Therapeutics, Inc. 13G/A Amendment 8 SLNO · 834203309	SLNO	834203309	5.6%	2,627,651	13G/A Amendment 8	4/30/2025 Event 3/31/2025
Nantahala Capital Management, LLC			5.6%	2,627,651
Wilmot B. Harkey			5.6%	2,627,651
Daniel Mack			5.6%	2,627,651
Xtant Medical Holdings, Inc. 13D XTNT · 98420P308	XTNT	98420P308	49.1%	68,394,000	13D	4/17/2025 Event 4/10/2025
Nantahala Capital Partners Limited Partnership			11.8%	16,380,396
Nantahala Capital Management, LLC			49.1%	68,394,000
Wilmot B. Harkey			49.1%	68,394,000
Daniel Mack			49.1%	68,394,000
Talphera, Inc. 13D/A Amendment 2 TLPH · 00444T209	TLPH	00444T209	11.7%	1,992,519	13D/A Amendment 2	4/3/2025 Event 3/31/2025
Nantahala Capital Management, LLC			11.7%	1,992,519
Wilmot B. Harkey			11.7%	1,992,519
Daniel Mack			11.7%	1,992,519
Talphera, Inc. 13D/A Amendment 1 TLPH · 00444T209	TLPH	00444T209	11.7%	1,992,519	13D/A Amendment 1	4/2/2025 Event 3/31/2025
Nantahala Capital Management, LLC			11.7%	1,992,519
Wilmot B. Harkey			11.7%	1,992,519
Daniel Mack			11.7%	1,992,519
America's Car-Mart, Inc. 13D/A Amendment 1 CRMT · 03062T105	CRMT	03062T105	7.8%	644,686	13D/A Amendment 1	3/12/2025 Event 3/10/2025
Nantahala Capital Management, LLC			7.8%	644,686
Wilmot B. Harkey			7.8%	644,686
Daniel Mack			7.8%	644,686
Eagle Pharmaceuticals, Inc. 13G/A Amendment 2 EGRX · 269796108	EGRX	269796108	38.1%	4,945,209	13G/A Amendment 2	2/19/2025 Event 2/16/2025
Nantahala Capital Management, LLC			38.1%	4,945,209
Wilmot B. Harkey			38.1%	4,945,209
Daniel Mack			38.1%	4,945,209
Eventbrite, Inc. 13G EB · 29975E109	EB	29975E109	7.3%	5,930,947	13G	2/14/2025 Event 12/31/2024
Nantahala Capital Management, LLC			7.3%	5,930,947
Wilmot B. Harkey			7.3%	5,930,947
Daniel Mack			7.3%	5,930,947
Establishment Labs Holdings Inc. 13G/A Amendment 5 ESTA · G31249108	ESTA	G31249108	6.1%	1,682,688	13G/A Amendment 5	2/14/2025 Event 12/31/2024
Nantahala Capital Management, LLC			5.9%	1,654,470
Wilmot B. Harkey			5.9%	1,654,470
Daniel Mack			6.1%	1,682,688
DarioHealth Corp. 13G/A Amendment 7 DRIO · 23725P209	DRIO	23725P209	10.0%	3,512,946	13G/A Amendment 7	2/14/2025 Event 12/31/2024
Nantahala Capital Management, LLC			10.0%	3,512,946
Wilmot B. Harkey			10.0%	3,512,946
Daniel Mack			10.0%	3,512,946
Conns, Inc. 13G/A Amendment 1 CONNQ · 208242107	CONNQ	208242107	5.6%	1,389,773	13G/A Amendment 1	2/14/2025 Event 12/31/2024
Nantahala Capital Management, LLC			5.6%	1,389,773
Wilmot B. Harkey			5.6%	1,389,773
Daniel Mack			5.6%	1,389,773
Cellectar Biosciences, Inc. 13G/A Amendment 2 CLRB · 15117F807	CLRB	15117F807	5.7%	2,507,125	13G/A Amendment 2	2/14/2025 Event 12/31/2024
Nantahala Capital Management, LLC			5.7%	2,507,125
Wilmot B. Harkey			5.7%	2,507,125
Daniel Mack			5.7%	2,507,125
Blacksky Technology Inc. 13G/A Amendment 1 BKSY · 09263B207	BKSY	09263B207	4.5%	1,377,060	13G/A Amendment 1	2/14/2025 Event 12/31/2024
Nantahala Capital Management, LLC			4.5%	1,377,060
Wilmot B. Harkey			4.5%	1,377,060
Daniel Mack			4.5%	1,377,060
Apyx Medical Corporation 13G APYX · 03837C106	APYX	03837C106	10.0%	3,493,235	13G	2/14/2025 Event 12/31/2024
Nantahala Capital Management, LLC			10.0%	3,493,235
Wilmot B. Harkey			10.0%	3,493,235
Daniel Mack			10.0%	3,493,235
Anebulo Pharmaceuticals, Inc. 13G ANEB · 034569103	ANEB	034569103	8.6%	3,547,398	13G	2/14/2025 Event 12/31/2024
Nantahala Capital Management, LLC			8.6%	3,547,398
Wilmot B. Harkey			8.6%	3,547,398
Daniel Mack			8.6%	3,547,398
Soleno Therapeutics, Inc. 13G/A Amendment 7 SLNO · 834203309	SLNO	834203309	10.0%	4,349,435	13G/A Amendment 7	2/14/2025 Event 12/31/2024
Nantahala Capital Management, LLC			10.0%	4,349,435
Wilmot B. Harkey			10.0%	4,349,435
Daniel Mack			10.0%	4,349,435
Surrozen, Inc. 13G/A Amendment 1 SRZN · 86889P208	SRZN	86889P208	10.0%	338,930	13G/A Amendment 1	2/14/2025 Event 12/31/2024
Nantahala Capital Management, LLC			10.0%	338,930
Wilmot B. Harkey			10.0%	338,930
Daniel Mack			10.0%	338,930
InspireMD, Inc. 13G/A Amendment 2 NSPR · 45779A846	NSPR	45779A846	10.0%	2,709,118	13G/A Amendment 2	2/14/2025 Event 12/31/2024
Nantahala Capital Management, LLC			10.0%	2,709,118
Wilmot B. Harkey			10.0%	2,709,118
Daniel Mack			10.0%	2,709,118
Optinose, Inc. 13G/A Amendment 1 OPTN · 68404V209	OPTN	68404V209	10.0%	1,006,572	13G/A Amendment 1	2/14/2025 Event 12/31/2024
Nantahala Capital Management, LLC			10.0%	1,006,572
Wilmot B. Harkey			10.0%	1,006,572
Daniel Mack			10.0%	1,006,572
Altisource Portfolio Solutions S.A. 13G ASPS · L0175J104	ASPS	L0175J104	7.8%	2,128,284	13G	2/14/2025 Event 12/31/2024
Nantahala Capital Management, LLC			7.8%	2,128,284
Wilmot B. Harkey			7.8%	2,128,284
Daniel Mack			7.8%	2,128,284
Zevra Therapeutics, Inc. 13G/A Amendment 2 ZVRA · 488445206	ZVRA	488445206	4.4%	2,340,333	13G/A Amendment 2	2/14/2025 Event 12/31/2024
Nantahala Capital Management, LLC			4.4%	2,340,333
Wilmot B. Harkey			4.4%	2,340,333
Daniel Mack			4.4%	2,340,333
Verastem, Inc. 13G/A Amendment 1 VSTM · 92337C203	VSTM	92337C203	10.0%	4,523,184	13G/A Amendment 1	2/14/2025 Event 12/31/2024
Nantahala Capital Management, LLC			10.0%	4,523,184
Wilmot B. Harkey			10.0%	4,523,184
Daniel Mack			10.0%	4,523,184
TELA Bio, Inc. 13G/A Amendment 1 TELA · 872381108	TELA	872381108	10.0%	3,974,326	13G/A Amendment 1	2/14/2025 Event 12/31/2024
Nantahala Capital Management, LLC			10.0%	3,974,326
Wilmot B. Harkey			10.0%	3,974,326
Daniel Mack			10.0%	3,974,326
Senti Biosciences, Inc. 13G SNTI · 81726A209	SNTI	81726A209	10.0%	509,283	13G	2/14/2025 Event 12/31/2024
Nantahala Capital Management, LLC			10.0%	509,283
Wilmot B. Harkey			10.0%	509,283
Daniel Mack			10.0%	509,283
Rezolute, Inc. 13G/A Amendment 2 RZLT · 76200L309	RZLT	76200L309	4.9%	2,857,982	13G/A Amendment 2	2/14/2025 Event 12/31/2024
Nantahala Capital Management, LLC			4.9%	2,857,982
Wilmot B. Harkey			4.9%	2,857,982
Daniel Mack			4.9%	2,857,982
Peloton Interactive, Inc. 13G/A Amendment 1 PTON · 70614W100	PTON	70614W100	3.4%	12,314,603	13G/A Amendment 1	2/14/2025 Event 12/31/2024
Nantahala Capital Management, LLC			3.4%	12,314,603
Wilmot B. Harkey			3.4%	12,314,603
Daniel Mack			3.4%	12,314,603
One Group Hospitality, Inc. 13G/A Amendment 1 STKS · 88338K103	STKS	88338K103	6.8%	2,087,394	13G/A Amendment 1	2/14/2025 Event 12/31/2024
Nantahala Capital Management, LLC			6.8%	2,087,394
Wilmot B. Harkey			6.8%	2,087,394
Daniel Mack			6.8%	2,087,394
Inhibikase Therapeutics, Inc. 13G IKT · 45719W205	IKT	45719W205	7.5%	5,298,624	13G	2/14/2025 Event 12/31/2024
Nantahala Capital Management, LLC			7.5%	5,298,624
Wilmot B. Harkey			7.5%	5,298,624
Daniel Mack			7.5%	5,298,624
IMAX Corporation 13G/A Amendment 1 04524E109		04524E109	2.7%	1,400,351	13G/A Amendment 1	2/14/2025 Event 12/31/2024
Nantahala Capital Management, LLC			2.7%	1,400,351
Wilmot B. Harkey			2.7%	1,400,351
Daniel Mack			2.7%	1,400,351
Fossil Group, Inc. 13G FOSL · 34988V106	FOSL	34988V106	6.3%	3,326,677	13G	2/14/2025 Event 12/31/2024
Nantahala Capital Management, LLC			6.3%	3,326,677
Wilmot B. Harkey			6.3%	3,326,677
Daniel Mack			6.3%	3,326,677
Evoke Pharma, Inc. 13D/A Amendment 3 EVOK · 30049G203	EVOK	30049G203	16.0%	254,639	13D/A Amendment 3	2/3/2025 Event 2/3/2025
Nantahala Capital Management, LLC			16.0%	254,639
Wilmot B. Harkey			16.0%	254,639
Daniel Mack			16.0%	254,639
Unicycive Therapeutics, Inc. 13G/A Amendment 5 UNCY · 90466Y103	UNCY	90466Y103	10.0%	10,879,142	13G/A Amendment 5	12/20/2024 Event 12/19/2024
Nantahala Capital Management, LLC			10.0%	10,879,142
Wilmot B. Harkey			10.0%	10,879,142
Daniel Mack			10.0%	10,879,142
Codexis, Inc. 13G/A Amendment 12 CDXS · 192005106	CDXS	192005106	4.3%	2,967,808	13G/A Amendment 12	11/14/2024 Event 9/30/2024
Nantahala Capital Management, LLC			4.3%	2,967,808
Wilmot B. Harkey			4.3%	2,967,808
Daniel Mack			4.3%	2,967,808
Cellectar Biosciences, Inc. 13G/A Amendment 1 CLRB · 15117F807	CLRB	15117F807	10.0%	3,677,739	13G/A Amendment 1	11/14/2024 Event 9/30/2024
Nantahala Capital Management, LLC			10.0%	3,677,739
Wilmot B. Harkey			10.0%	3,677,739
Daniel Mack			10.0%	3,677,739
Blacksky Technology Inc 13G BKSY · 09263B207	BKSY	09263B207	8.6%	2,450,000	13G	11/14/2024 Event 9/30/2024
Nantahala Capital Management, LLC			8.6%	2,450,000
Wilmot B. Harkey			8.6%	2,450,000
Daniel Mack			8.6%	2,450,000
Bioventus Inc. 13G/A Amendment 2 BVS · 09075A108	BVS	09075A108	6.7%	4,350,870	13G/A Amendment 2	11/14/2024 Event 9/30/2024
Nantahala Capital Management, LLC			6.7%	4,350,870
Wilmot B. Harkey			6.7%	4,350,870
Daniel Mack			6.7%	4,350,870
Viemed Healthcare, Inc. 13G/A Amendment 1 VMD · 92663R105	VMD	92663R105	2.9%	1,135,122	13G/A Amendment 1	11/14/2024 Event 9/30/2024
Nantahala Capital Management, LLC			2.9%	1,135,122
Wilmot B. Harkey			2.9%	1,135,122
Daniel Mack			2.9%	1,135,122
Zevra Therapeutics, Inc. 13G/A Amendment 1 ZVRA · 488445206	ZVRA	488445206	5.6%	2,924,021	13G/A Amendment 1	11/14/2024 Event 9/30/2024
Nantahala Capital Management, LLC			5.6%	2,924,021
Wilmot B. Harkey			5.6%	2,924,021
Daniel Mack			5.6%	2,924,021
Xtant Medical Holdings, Inc. 13G XTNT · 98420P308	XTNT	98420P308	8.2%	11,394,000	13G	11/14/2024 Event 9/30/2024
Nantahala Capital Management, LLC			8.2%	11,394,000
Wilmot B. Harkey			8.2%	11,394,000
Daniel Mack			8.2%	11,394,000
Vistagen Therapeutics, Inc. 13G/A Amendment 1 VTGN · 92840H400	VTGN	92840H400	10.0%	2,834,336	13G/A Amendment 1	11/14/2024 Event 9/30/2024
Nantahala Capital Management, LLC			10.0%	2,834,336
Wilmot B. Harkey			10.0%	2,834,336
Daniel Mack			10.0%	2,834,336
Verastem, Inc. 13G VSTM · 92337C203	VSTM	92337C203	10.0%	4,052,204	13G	11/14/2024 Event 9/30/2024
Nantahala Capital Management, LLC			10.0%	4,052,204
Wilmot B. Harkey			10.0%	4,052,204
Daniel Mack			10.0%	4,052,204
uniQure N.V. 13G/A Amendment 7 QURE · N90064101	QURE	N90064101	6.1%	2,982,013	13G/A Amendment 7	11/14/2024 Event 9/30/2024
Nantahala Capital Management, LLC			6.1%	2,982,013
Wilmot B. Harkey			6.1%	2,982,013
Daniel Mack			6.1%	2,982,013
Unicycive Therapeutics, Inc. 13G/A Amendment 4 UNCY · 90466Y103	UNCY	90466Y103	10.0%	10,159,349	13G/A Amendment 4	11/14/2024 Event 9/30/2024
Nantahala Capital Management, LLC			10.0%	10,159,349
Wilmot B. Harkey			10.0%	10,159,349
Daniel Mack			10.0%	10,159,349
Benitec Biopharma Inc. 13G BNTC · 08205P209	BNTC	08205P209	9.7%	1,038,371	13G	11/14/2024 Event 9/30/2024
Nantahala Capital Management, LLC			9.7%	1,038,371
Wilmot B. Harkey			9.7%	1,038,371
Daniel Mack			9.7%	1,038,371
Titan Machinery Inc. 13G TITN · 88830R101	TITN	88830R101	7.0%	1,625,276	13G	11/14/2024 Event 9/30/2024
Nantahala Capital Management, LLC			7.0%	1,625,276
Wilmot B. Harkey			7.0%	1,625,276
Daniel Mack			7.0%	1,625,276
Theratechnologies Inc. 13G/A Amendment 1 THTX · 88338H704	THTX	88338H704	5.8%	2,682,228	13G/A Amendment 1	11/14/2024 Event 9/30/2024
Nantahala Capital Management, LLC			5.8%	2,682,228
Wilmot B. Harkey			5.8%	2,682,228
Daniel Mack			5.8%	2,682,228
TELA Bio, Inc. 13G TELA · 872381108	TELA	872381108	7.7%	1,915,126	13G	11/14/2024 Event 9/30/2024
Nantahala Capital Management, LLC			7.7%	1,915,126
Wilmot B. Harkey			7.7%	1,915,126
Daniel Mack			7.7%	1,915,126
Surrozen, Inc. 13G SRZN · 86889P208	SRZN	86889P208	10.0%	335,031	13G	11/14/2024 Event 9/30/2024
Nantahala Capital Management, LLC			10.0%	335,031
Wilmot B. Harkey			10.0%	335,031
Daniel Mack			10.0%	335,031
Strata Skin Sciences, Inc. 13G/A Amendment 7 SSKN · 86272A305	SSKN	86272A305	9.7%	403,917	13G/A Amendment 7	11/14/2024 Event 9/30/2024
Nantahala Capital Management, LLC			9.7%	403,917
Wilmot B. Harkey			9.7%	403,917
Daniel Mack			9.7%	403,917
Soleno Therapeutics, Inc 13G/A Amendment 6 SLNO · 834203309	SLNO	834203309	10.0%	3,951,287	13G/A Amendment 6	11/14/2024 Event 9/30/2024
Nantahala Capital Management, LLC			10.0%	3,951,287
Wilmot B. Harkey			10.0%	3,951,287
Daniel Mack			10.0%	3,951,287
RumbleOn, Inc. 13G/A Amendment 5 RDNW · 781386305	RDNW	781386305	8.7%	3,066,537	13G/A Amendment 5	11/14/2024 Event 9/30/2024
Nantahala Capital Management, LLC			8.7%	3,066,537
Wilmot B. Harkey			8.7%	3,066,537
Daniel Mack			8.7%	3,066,537
Rezolute, Inc. 13G/A Amendment 1 RZLT · 76200L309	RZLT	76200L309	8.6%	4,966,717	13G/A Amendment 1	11/14/2024 Event 9/30/2024
Nantahala Capital Management, LLC			8.6%	4,966,717
Wilmot B. Harkey			8.6%	4,966,717
Daniel Mack			8.6%	4,966,717
Red Violet, Inc. 13G/A Amendment 3 RDVT · 75704L104	RDVT	75704L104	3.3%	452,466	13G/A Amendment 3	11/14/2024 Event 9/30/2024
Nantahala Capital Management, LLC			3.3%	452,466
Wilmot B. Harkey			3.3%	452,466
Daniel Mack			3.3%	452,466
Peloton Interactive, Inc. 13G PTON · 70614W100	PTON	70614W100	5.2%	18,643,331	13G	11/14/2024 Event 9/30/2024
Nantahala Capital Management, LLC			5.2%	18,643,331
Wilmot B. Harkey			5.2%	18,643,331
Daniel Mack			5.2%	18,643,331